1997-62-2

Basic information

• Product Name: 1-acetyl-3-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
• Synonyms: 2H-Benzimidazol-2-one, 1-acetyl-3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1,3-dihydro-
• CAS NO: 1997-62-2
• Molecular Formula: C₂₄H₂₆FN₃O₃
• Molecular Weight: 423.4799
• Mol File: 1997-62-2.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 588.5°C at 760 mmHg
• Flash Point: 309.7°C
• Density: 1.268g/cm³
• Vapor Pressure: 7.87E-14mmHg at 25°C
• Refractive Index: 1.598
• CAS DataBase Reference: 1-acetyl-3-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-acetyl-3-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one(1997-62-2)
• EPA Substance Registry System: 1-acetyl-3-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one(1997-62-2)

Safety Data

• Hazardous Substances Data: 1997-62-2(Hazardous Substances Data)

Usage

Explanation

Different sources of media describe the Explanation of 1997-62-2 differently. You can refer to the following data:
1. The molecular formula represents the number of atoms of each element present in a molecule of the compound.
2. Benzimidazolone derivative
2. The compound is derived from benzimidazolone, which is a core structure in the molecule.
3. Piperidinyl group
4. Fluoro-substituted phenyl group
3. The compound contains a phenyl group (a six-membered carbon ring with alternating single and double bonds) with a fluorine atom substitution, which can influence the compound's properties and interactions.
5. Acetyl group
4. The presence of an acetyl group (a two-carbon functional group derived from acetic acid) can affect the compound's reactivity and potential pharmaceutical applications.
6. Potential pharmaceutical applications
5. Due to its structural characteristics, the compound may have the ability to interact with biological systems in a specific way, which could be useful in the development of new medications.
7. Further research and testing needed
6. To fully understand the compound's potential medicinal properties and how it can be utilized, additional research and testing are required.